POTASSIUM CHLORIDE sustained-release oral

Select language:
On this page


    Prescription under medical supervision


    Therapeutic action

    • Potassium supplement


    • Hypokalaemia induced by :
      • thiazide diuretics (e.g. hydrochlorothiazide)
      • loop diuretics (e.g. furosemide)

    Forms and strengths

    • 600 mg potassium chloride sustained-release tablet (8 mmol of K+)


    • Adult: 15 to 25 mmol daily = 1 tablet 2 to 3 times daily
    • Do not exceed indicated doses if potassium serum levels cannot be measured.


    • According to clinical response and duration of diuretic treatment

    Contra-indications, adverse effects, precautions

    • Administer with caution and reduce dosage in elderly patients and in patients with renal impairment (risk of hyperkalaemia).
    • Do not combine with spironolactone and angiotensin-converting-enzyme inhibitors (e.g. enalapril).
    • May cause: hyperkalaemia, gastroduodenal ulcerations, diarrhoea, nausea and vomiting.
    • Pregnancy: no contra-indication
    • Breast-feeding: no contra-indication


    • Take with or at the end meals in order to reduce the risk of gastrointestinal ulcerations.
    • Hypokalaemia is defined as a serum potassium concentration below 3.5 mmol/litre.
    • If tablets are not available, a lack of potassium may be corrected by a diet rich in dates, bananas, mangos, oranges, tomatoes, etc.


    – Below 25 °C